| Financial Year |
March 31 2022 |
| Monetary Funds |
203,522,653.27 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
23,264,395.40 |
| Advances to Suppliers |
1,888,025.41 |
| Other Receivables |
127,411,350.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
127,057.94 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
648,185.63 |
| Total Current Assets |
356,861,667.99 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
268,674,392.01 |
| Investment Properties |
-- |
| Fixed Assetes |
2,409,974.32 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
25,780,000.00 |
| R&D expenses |
-- |
| Goodwill |
714,402,384.49 |
| Long-Term Deferred and Prepaid Expenses |
589,857.86 |
| Deferred Income Tax Assets |
-- |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,053,759,870.19 |
| Total Assets |
1,410,621,538.18 |
| Short-Term Loans |
694,441,568.75 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
12,071,306.63 |
| Accounts Received In Advance |
4,581,492.69 |
| Employee Compensation Payable |
3,275,834.00 |
| Taxes Payable |
276,608.18 |
| Interest Payable |
82,514,809.71 |
| Dividend Payable |
-- |
| Other payables |
656,346,660.94 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
825,592.85 |
| Other Current Liabilities |
10,074,087.60 |
| Sub-Total of Current Liabilities |
1,381,893,151.64 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,790,231.79 |
| Total Liabilities |
1,383,683,383.43 |
| Paid-In Capital(Or Share Stock) |
521,794,388.00 |
| Capital Surplus |
508,729,972.21 |
| Surplus Reserve |
35,306,384.04 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-711,627,508.36 |
| Minority Stockholder's Interest |
-50,451.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
26,988,606.53 |
| Owner's Equity（Stockholder's Equity） |
26,938,154.75 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,410,621,538.18 |
